NCT07849595

Brief Summary

The overall goal of this project is to determine if measuring blood pressure at home and staying in contact with a team of pharmacists and physicians to manage participants' blood pressure is useful. The study will enroll 552 participants who are seen at the University of Alabama at Birmingham 1917 Dewberry Clinic and Vanderbilt Comprehensive Care Center. Half of the participants (276 patients) will be asked to measure blood pressure at home, and half of the participants (276 patients) will continue to receive usual care. Participants who measure blood pressure at home will also meet with a pharmacist weekly over the phone to discuss blood pressure readings and have blood pressure medications prescribed if needed. This program will last 6 months.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
572

participants targeted

Target at P75+ for not_applicable hypertension

Timeline
53mo left

Started Feb 2027

Longer than P75 for not_applicable hypertension

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 24, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

September 30, 2026

Completed
4 months until next milestone

Study Start

First participant enrolled

February 1, 2027

Expected
4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2031

4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2031

Last Updated

September 30, 2026

Status Verified

September 1, 2026

Enrollment Period

4 years

First QC Date

September 24, 2026

Last Update Submit

September 24, 2026

Conditions

HypertensionBlood Pressure Monitoring

Keywords

Cardiovascular diseasesDelivery of Health CarePatient Care ManagementHealth Services AdministrationTelemedicineVascular Diseases

Outcome Measures

Primary Outcomes (1)

  • Total Number of Enrolled Participants with Blood Pressure Control

    The number of enrolled participants with blood pressure control

    Time Frame: 12 weeks (3 months) from randomization

Secondary Outcomes (1)

  • Number of Participants in the Intervention with Patient-Reported Outcomes

    Time Frame: 24 weeks (6 months) from randomization

Study Arms (2)

Remote Blood Pressure Monitoring + Telehealth

ACTIVE COMPARATOR

Participants will undergo remote blood pressure monitoring and pharmacist led telehealth intervention for blood pressure management

Behavioral: Remote Blood Pressure Monitoring + Telehealth

Usual Care

NO INTERVENTION

Participants receive usual care from providers to manage blood pressure

Interventions

Remote Blood Pressure Monitoring + TelehealthBEHAVIORAL

Participants will undergo remote blood pressure monitoring and pharmacist led telehealth intervention for blood pressure management

Also known as: Intervention group
Remote Blood Pressure Monitoring + Telehealth

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≥18 years
  • Ability to speak English
  • Seen at UAB's 1917 Dewberry Clinic or Vanderbilt's Comprehensive Care Clinic
  • Blood pressure at Clinic: Systolic BP ≥ 130 mmHg or Diastolic BP ≥ 80 mmHg
  • Have a cellphone with video capability

You may not qualify if:

  • Lack of willingness or inability to provide written informed consent
  • Individuals who work overnight or second shift
  • History of known major arrhythmias
  • Currently pregnant or breastfeeding
  • Arm circumference \>50 cm. \*The upper limit for the largest BP cuff for oscillometric BP devices is typically 50-52 cm; data from the National Health and Nutrition Examination Survey, 2011-2016 indicated that \<1% of US adults have an arm circumference \>50 cm, so this will have minimal effect on our study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

HypertensionCardiovascular DiseasesVascular Diseases

Interventions

Telemedicine

Intervention Hierarchy (Ancestors)

Delivery of Health CarePatient Care ManagementHealth Services Administration

Study Officials

  • Lama Ghazi, MD, PhD

    University of Alabama at Birmingham

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Tammi Thomas

CONTACT

205-934-7839tammithomas@uabmc.edu

Bernadette Johnson

CONTACT

205-934-7329bajohnson@uabmc.edu

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principle Investigator

Study Record Dates

First Submitted

September 24, 2026

First Posted

September 30, 2026

Study Start (Estimated)

February 1, 2027

Primary Completion (Estimated)

February 1, 2031

Study Completion (Estimated)

May 31, 2031

Last Updated

September 30, 2026

Record last verified: 2026-09

Data Sharing

IPD Sharing
Will not share

While the investigators do not anticipate generating research tools, the investigators are committed to adhering to the National Institutes of Health (NIH) Research Tools Policy to ensure that any resources developed under this award are readily available to qualified researchers. If an NIH-defined research tool is developed, the investigators will collaborate with University of Alabama at Birmingham Commercialization and Licensing Office and all participating institutions to define ownership, protect intellectual property, and establish a dissemination strategy that ensures appropriate access and compliance with NIH guidelines.